UCLA Scholars in Oncologic Molecular Imaging(SOMI)

描述(由申请人提供)：加州大学洛杉矶分校的肿瘤分子成像(SOMI)学者是一个多元化的培训计划，汇集了9个系，主要来自加州大学洛杉矶分校的生命和健康科学，以培训下一代分子成像科学家。肿瘤学分子成像是一个迅速发展的领域，它结合了细胞/分子生物学、化学、生物医学物理、生物数学、药理学、成像科学和临床医学等学科，以促进癌症的研究、诊断和治疗。加州大学洛杉矶分校分子和医学药理学系(DMMP)和克伦普分子成像研究所(CIMI)是推动分子成像领域向前发展的关键参与者。在加州大学洛杉矶分校琼森综合癌症中心(JCCC)的初步关键种子支持下，加州大学洛杉矶分校帮助分子成像领域迅速发展。加州大学洛杉矶分校分子成像计划的资金来源现在包括能源部、活体细胞和分子仿制中心(ICMIC)的NCI(P50)赠款、几个NCI R01‘a和NCI小动物成像资源计划(SAIRP)赠款。培训下一代科学家的时机已经成熟，他们可以在研究完整生物体内的癌症生物学/治疗学所需的各个领域之间架起桥梁。 在目前的提案中，我们的目标是通过29名基础科学和临床教师导师组成的多样化小组培训19名博士后研究员，这些导师代表7个计划领域、6门正规课程，涉及分子成像、药理学、癌症生物学、癌症免疫学、病毒学、基因疗法和临床血液学/肿瘤学。学员将被招募到一个为期三年的项目中，并将在至少两名导师的指导下完成课程和研究。此外，他们将在第三年进行模拟拨款提案，以帮助他们在拨款申请过程中获得经验和信心。将特别注意招募少数族裔申请者。培训委员会将仔细监督所有SOMI学员的过程，咨询委员会将监督整个SOMI计划。SOMI的毕业生将接受独特的培训，利用最先进的技术在生物体背景下研究癌症。我们是肿瘤学分子成像的发展领域。

DESCRIPTION (provided by applicant): The UCLA scholars in Oncologic Molecular Imaging (SOMI) is a diverse training program bringing together 9 Departments, predominantly from the UCLA Life and Health Sciences, in order to train the next generation of molecular imaging scientist. Oncologic molecular imaging is a rapidly growing area which combines the disciplines of cell/molecular biology, chemistry, biomedical physics, biomathematics, pharmacology, imaging sciences, and clinical medicine to advance cancer research, diagnosis and management. The UCLA Department of Molecular & Medical Pharmacology (DMMP) and the Crump Institute for Molecular Imaging (CIMI) are key players in helping to move the field of molecular molecular imaging forward. With initial critical seed support from the UCLA Jonson Comprehensive Cancer Center (JCCC), UCLA has helped to rapidly grow the field of molecular imaging. Funding sources for the molecular imaging program at UCLA now include the Department of Energy, NCI (P50) In Vivo Cellular and Molecular Imigaing Center (ICMIC) grant, Several NCI R01'a, and NCI Small Animal Imaging Resource Program (SAIRP) grant. The time is ripe for training the next generation of scientists that can bridge the various fields needed to study cancer biology/therapeutics in intact living organisms. In the current proposal, our goals are to train 19 post-doctoral fellows through a diverse group of 29 basic science and clinical faculty mentors representing 7 program areas, 6 formal courses in molecular imaging, pharmacology, cancer biology, cancer immunology, virology, gene therapy, and clinical hematology/oncology rounds. Fellows will be recruited into a three year program and will complete coursework and research with at least two mentors. Furthermore, they will do a mock grant proposal in their third year to help them gain experience and confidence in the grant application process. Special attention will be given towards recruiting minority applicants. A Training Committee will carefully monitor the process of all SOMI trainees, and an Advisory Committee will monitor the entire SOMI program. Graduates of SOMI will be uniquely trained to study cancer in an organism context with state-of-the-art technologies. We are evolving area of the oncologic molecular imaging.